Glutamine Market - By Type , By Form , By End-use Industry , By Geography - Global Opportunity Analysis & Industry Forecast, 2024 - 2030

Report Code: CMR 0841 Report Format: PDF + Excel

Glutamine Market Overview


Glutamine Market Size is forecast to reach $ 172 Million by 2030, at a CAGR of 3.60% during forecast period 2024-2030. Glutamine is an amino acid and a derivative of glutamic acid. They can be categorized into L-glutamine and D-glutamine and is used in various end-uses such as pharmaceutical, dietary supplement, cosmetics & personal care and others. The expansion of the glutamine market is primarily driven by its usage in the cosmetic & personal care industry. According to the European Trade Association for the Cosmetics and Personal Care Industry, the total sale of the cosmetics and personal care industry in Europe was valued at US$94.6 million in 2021, an increase of 4.3% as compared to US$87.6 in 2020. An increase in the production of cosmetic & personal care products along with the growth of the pharmaceutical industry is expected to drive the growth of the glutamine market size in the upcoming years. On the other hand, the availability of substitutes may confine the growth of the market. In 2020, the surge in the COVID-19 pandemic negatively impacted cosmetic production activities, thus, temporarily affecting the growth of the glutamine industry. However, a steady recovery in cosmetic production has been witnessed since 2021, which in turn, is driving the demand for Glutamine.

Glutamine Market Report Coverage

The "Glutamine Market Report – Forecast (2024-2030)” by IndustryARC, covers an in-depth analysis of the following segments in the Glutamine Market.

By Type: L-Glutamine and D-Glutamine.
 
By Form: Powder, Capsules & Tablets and Liquid.
 
By End-use Industry: Pharmaceuticals, Dietary Supplement, Cosmetics & Personal Care (Skin Care, Hair Care, Others) and Others.
 
By Geography: North America (the USA, Canada and Mexico), Europe (the UK, Germany, France, Italy, the Netherlands, Spain, Denmark, Belgium and the Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia and New Zealand, Indonesia, Taiwan, Malaysia and the Rest of APAC), South America (Brazil, Argentina, Colombia, Chile and the Rest of South America) and the Rest of the World [the Middle East (Saudi Arabia, the UAE, Israel and the Rest of the Middle East) and Africa (South Africa, Nigeria and the Rest of Africa)].

Key Takeaways

  • Powder form held a significant share of the Glutamine Market in 2021. Its wide range of characteristics, along with ease of storage and transportation made it stand out in comparison to other forms of Glutamine in the market.
  • The Pharmaceutical industry held the largest share of the Glutamine Market in 2021, owing to the increasing production from pharmaceutical sectors worldwide. For instance, recent insights from Atradius state that global pharmaceutical production increased significantly by 13.6% in 2021 as compared to 2020.
  • North America dominated the Glutamine Market in 2021, owing to the increasing demand for Glutamine from the pharmaceutical sector in the region. According to Atradius, the United States accounted for 22% of the total global pharmaceutical production in 2021.
  • A detailed analysis of strengths, weaknesses, opportunities and threats would be provided in the Glutamine Market Report.
Figure: Glutamine Market Share, By Geography, 2021 (%)
For More Details on This Report - Request for Sample

Glutamine Market Segment Analysis – by Form

Powder form held a significant share of over 20% of the Glutamine Market in 2021, owing to its range of characteristics and benefits over other forms of glutamine. Glutamine in powder form has better physicochemical stability in comparison to other forms of glutamine. This makes them ideal for use in the production of pharmaceutical products and dietary supplement that helps boost immune function and wound healing. Moreover, glutamine in powder form offers higher flexibility in compounding solids, longer shelf life and is easier to store and transport. Furthermore, the manufacturing of powder form is more economical and cost-effective. All of these benefits of powder form are driving its demand over other forms of glutamine. For instance, Optimum Nutrition Inc., a glutamine manufacturer based in the United States, offers glutamine powder as a dietary supplement. Such benefits of Glutamine powder are expected to boost the market growth during the forecast period.

Glutamine Market Segment Analysis – by End-use Industry

The pharmaceutical industry dominated the Glutamine Market with a share of over 25% in 2021, owing to the increasing production from pharmaceutical sectors worldwide. According to the European Federation of Pharmaceutical Industries and Associations (EFPIA), the total production of pharmaceuticals including capsules, tablets and other products in Europe was valued at EUR 310,000 million (approx. US$354,080.76 million) in 2020. L-glutamine is an amino acid and a derivative of glutamic acid and is primarily used in the production of medicines used for treating sickle cell disease, abdominal pain, irritable bowel syndrome and other conditions. It also aids in improving a body’s immunity function and wound-healing capability after surgery. Thus, such increasing production from pharmaceutical sectors is expected to increase the demand for glutamine. This is expected to expand the glutamine market size during the forecast period.

Glutamine Market Segment Analysis – by Geography

North America held a dominant share of over 35% of the Glutamine Market in 2021. The consumption of glutamine is particularly high in this region due to its increasing demand from the pharmaceutical sector. According to the European Federation of Pharmaceutical Industries and Associations (EFPIA), the U.S. and Canada accounted for 49.1% of the total pharmaceutical market in 2021. Moreover, recent insights from the International Trade Administration state that the total consumption of pharmaceutical products in Mexico reached up to US$11.1 billion in 2020, representing an increase of 2.8% from US$10.8 billion in 2019. In this way, such surging growth of the pharmaceutical sector in multiple countries across the region is expected to increase the demand for glutamine for the production of medicines used for treating several medical conditions such as sickle cell disease, abdominal pain, irritable bowel syndrome and more. This is anticipated to drive the growth of the market during the forecast period.

Glutamine Market Drivers

An increase in the production of cosmetic & personal care products:

Glutamine is primarily used in the production of cosmetics & skin care products as it helps in skin healing & hydration, generates more collagen, increases skin cell turnover and acts as an antioxidant for the skin. According to the International Trade Administration (ITA), the cosmetics & personal care industry of South Korea was valued at US$9.4 billion in 2019, with total local cosmetic production increasing by 4.9% in comparison to the previous year. Moreover, according to a study published on Fashion Network, skin care and sun care products produced an average annual growth of 5.6% in 2020. Hence, such surging production of cosmetics and personal care products is expected to increase the demand for glutamine, owing to their above-mentioned benefits. This is expected to accelerate the growth of the Glutamine market in the upcoming years.

Growth of the pharmaceutical industry:

L-glutamine is an amino acid and a derivative of glutamic acid that is commonly used in the pharmaceutical industry for the production of medicines used for treating sickle cell disease, abdominal pain, irritable bowel syndrome and other conditions. It also helps in improving a body’s immunity function and wound-healing capability after surgery. According to the Brazilian Chemical Industry Association, the production of the pharmaceutical industry in Brazil was valued at US$16.1 billion in 2021, an increase of 2.6% from US$15.7 billion in 2020. Moreover, according to the Government of Japan Ministry of Health, Labor and Welfare (MHLW), the production of pharmaceuticals in Japan was valued at US$87.03 million in 2019, an increase of 39% in comparison to the previous year. Thus, such surging growth in the pharmaceutical sector across multiple regions is expected to accelerate the growth of the market in the upcoming years.

Glutamine Market Challenge

Availability of substitutes:

Glutamine has several substitutes such as carnitine (L-carnitine), bromelain, creatine and more in the market. These substitutes have similar physical properties and performance which may restrict the market growth. For instance, carnitine is widely used as a substitute for glutamine in major end-users such as cosmetics & personal care, pharmaceutical and dietary supplement, owing to their range of benefits. Carnitine is commonly used in skin care products for multiple applications such as skin regeneration, minimizing the secretion of sebum and enhancing the skin tone. Moreover, it is also used as a dietary supplement, particularly for athletes, owing to its ability to convert body fat into energy. Thus, the availability of such alternatives with similar properties may limit the growth of the Glutamine industry during the forecast period.

Glutamine Industry Outlook

Technology launches, acquisitions and increased R&D activities are key strategies adopted by players in the Glutamine Market. The top companies in the Glutamine Market are:

  1. Ajinomoto Co., Inc.
  2. NOW Foods
  3. Evonik
  4. Optimum Nutrition Inc.
  5. Nutritech
  6. Dymatize Enterprises LLC
  7. Allmax Nutrition Inc.
  8. Nutri Advanced Ltd.
  9. Battery Nutrition Limited.
  10. Kyowa Hakko Kirin Co., Ltd.

Key Market Players:

The Top 5 companies in the Meningitis Diagnostic Testing Market are:

  1. Ajinomoto Co., Inc.
  2. Kyowa Hakko Bio Co.
  3. Daesang Corporation
  4. Tocris Bioscience
  5. ADM

For more Chemicals and Materials Market reports, please click here

1. Glutamine Market - Market Overview
    1.1 Definitions and Scope
2. Glutamine Market - Executive Summary
    2.1 Key Trends by Type
    2.2 Key Trends by Form
    2.3 Key Trends by End-use
    2.4 Key Trends by Geography
3. Glutamine Market – Comparative analysis
    3.1 Market Share Analysis - Major Companies
    3.2 Product Benchmarking - Major Companies
    3.3 Top 5 Financials Analysis
    3.4 Patent Analysis - Major Companies
    3.5 Pricing Analysis (ASPs will be provided)
4. Glutamine Market - Startup companies Scenario Premium 
    4.1 Major startup company analysis:
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Product portfolio
        4.1.4 Venture Capital and Funding Scenario
5. Glutamine Market – Market Entry Scenario Premium 
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing Business Index
    5.3 Successful Venture Profiles
    5.4 Customer Analysis – Major companies
6. Glutamine Market - Market Forces
    6.1 Market Drivers
    6.2 Market Constraints
    6.3 Porter's Five Force Model
        6.3.1 Bargaining Power of Suppliers
        6.3.2 Bargaining Powers of Buyers
        6.3.3 Threat of New Entrants
        6.3.4 Competitive Rivalry
        6.3.5 Threat of Substitutes
7. Glutamine Market – Strategic Analysis
    7.1 Value/Supply Chain Analysis
    7.2 Opportunity Analysis
    7.3 Product/Market Life Cycle
    7.4 Distributor Analysis – Major Companies
8. Glutamine Market – by Type (Market Size - US$ Million/Billion)
    8.1 L-Glutamine
    8.2 D-Glutamine
9. Glutamine Market – by Form (Market Size - US$ Million/Billion)
    9.1 Powder
    9.2 Capsules & Tablets
    9.3 Liquid
10. Glutamine Market – by End-use (Market Size - US$ Million/Billion)
    10.1 Pharmaceutical
    10.2 Dietary Supplement
    10.3 Cosmetics & Personal Care
        10.3.1 Skin Care
        10.3.2 Hair Care
        10.3.3 Others
    10.4 Others
11. Glutamine Market - by Geography (Market Size - US$ Million/Billion)
    11.1 North America
        11.1.1 The USA
        11.1.2 Canada
        11.1.3 Mexico
    11.2 Europe
        11.2.1 The UK
        11.2.2 Germany
        11.2.3 France
        11.2.4 Italy
        11.2.5 The Netherlands
        11.2.6 Spain
        11.2.7 Denmark
        11.2.8 Belgium
        11.2.9 The Rest of Europe
    11.3 Asia-Pacific
        11.3.1 China
        11.3.2 Japan
        11.3.3 India
        11.3.4 South Korea
        11.3.5 Australia and New Zealand
        11.3.6 Indonesia
        11.3.7 Taiwan
        11.3.8 Malaysia
        11.3.9 The Rest of APAC
    11.4 South America
        11.4.1 Brazil
        11.4.2 Argentina
        11.4.3 Colombia
        11.4.4 Chile
        11.4.5 The Rest of South America
    11.5 The Rest of the World
        11.5.1 The Middle East
            11.5.1.1 Saudi Arabia
            11.5.1.2 The UAE
            11.5.1.3 Israel
            11.5.1.4 The Rest of the Middle East
        11.5.2 Africa
            11.5.2.1 South Africa
            11.5.2.2 Nigeria
            11.5.2.3 The Rest of Africa
12. Glutamine Market – Entropy
    12.1 New Product Launches
    12.2 M&As, Collaborations, JVs and Partnerships
13. Glutamine Market – Industry/Segment Competition Landscape 
    13.1 Company Benchmarking Matrix – Major Companies
    13.2 Market Share at Global Level - Major companies
    13.3 Market Share by Key Geography - Major companies
    13.4 Market Share at Country Level - Major companies
    13.5 Market Share by Key Type/Product category - Major companies
14. Glutamine Market – Key Company List by Country Premium 
15. Glutamine Market Company Analysis - Business Overview, Product Portfolio, Financials and Developments
    15.1 Ajinomoto Co., Inc.
    15.2 Kyowa Hakko Bio Co.
    15.3 Daesang Corporation
    15.4 Tocris Bioscience
    15.5 ADM
 
*"Financials would be provided to private companies on best-efforts basis."
Connect with our experts to get customized reports that best suit your requirements. Our reports include global-level data, niche markets and competitive landscape.